Harbour Investments, Inc. Sorrento Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $1,240 - $2,330	1,000 Added 83.33%	2,200 $4,000
Q4 2021 Feb 16, 2022	SELL	$4.65 - $7.23 $26,495 - $41,196	-5,698 Reduced 82.6%	1,200 $6,000
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $548 - $813	74 Added 1.08%	6,898 $53,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $1,250 - $1,970	-197 Reduced 2.81%	6,824 $66,000
Q1 2021 Aug 17, 2021	BUY	$7.03 - $16.51 $49,336 - $115,867	7,018 Added 233933.33%	7,021 $58,000

Q1 2021 May 12, 2021	BUY	$7.03 - $16.51 $21 - $49	3 New	3 $0

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.